Patterns of acquired mutations in estrogen receptor-positive metastatic breast cancer (MBC) patients identified by comprehensive genomic profiling (CGP)

被引：0
|
作者：
McGregor, K. [1 ]
Ross, J. S. [2 ]
Danziger, N. A. [3 ]
Sokol, E. S. [4 ]
Venstrom, J. [5 ]
Chung, J. H. [5 ]
Lee, J. [5 ]
Alexander, B. [5 ]
Schrock, A. B. [5 ]
Tukachinsky, H. [1 ]
机构：
[1] Fdn Med Inc, Med Affairs, Boston, MA USA
[2] Fdn Med, Cambridge, MA USA
[3] Fdn Med Inc, Pathol, Cambridge, MA USA
[4] Fdn Med Inc, Canc Genom, Cambridge, MA USA
[5] Fdn Med, Clin Dev, Boston, MA USA
来源：
ANNALS OF ONCOLOGY | 2020年 / 31卷
关键词：
D O I：
10.1016/j.annonc.2020.08.407
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
305P
引用
收藏
页码：S364 / S364
页数：1
相关论文
共 50 条
  • [41] Estrogen receptor-positive breast cancer: a multidisciplinary challenge
    Zwart, Wilbert
    Theodorou, Vasiliki
    Carroll, Jason S.
    WILEY INTERDISCIPLINARY REVIEWS-SYSTEMS BIOLOGY AND MEDICINE, 2011, 3 (02) : 216 - 230
  • [42] Risk factors for estrogen receptor-positive breast cancer
    Hwang, ES
    Chew, T
    Shiboski, S
    Farren, G
    Benz, CC
    Wrensch, M
    ARCHIVES OF SURGERY, 2005, 140 (01) : 58 - 62
  • [43] Metastasis Dormancy in Estrogen Receptor-Positive Breast Cancer
    Zhang, Xiang H. -F.
    Giuliano, Mario
    Trivedi, Meghana V.
    Schiff, Rachel
    Osborne, C. Kent
    CLINICAL CANCER RESEARCH, 2013, 19 (23) : 6389 - 6397
  • [44] Differential genomic profiling of progesterone receptor (PR) negative, estrogen receptor (ER) positive HER2-negative metastatic breast cancer (MBC) through circulating tumor DNA
    Gerratana, Lorenzo
    Davis, Andrew
    Medford, Arielle
    Reduzzi, Carolina
    Clifton, Katherine
    Podany, Emily
    Hensing, Whitney
    Velimirovic, Marko
    Shah, Ami N.
    Foffano, Lorenzo
    Arcos, Laura Munoz
    Nicolo, Eleonora
    Dai, Charles S.
    Keenan, Jennifer
    Behdad, Amir
    Wander, Seth
    Gradishar, William
    Ma, Cynthia
    Puglisi, Fabio
    Bardia, Aditya
    Cristofanilli, Massimo
    CANCER RESEARCH, 2024, 84 (09)
  • [45] Clinicopathologic characterization and comprehensive genomic profiling (CGP) of advanced breast cancer patients with fibroblast growth factor receptor (FGFR) alterations
    Alvarez, R. H.
    Thomas, J. W.
    Kramer, K.
    Niu, J.
    Ahn, E.
    McKnight, J. E.
    Dhillon, N.
    Pabbathi, H.
    Johnson, A. T.
    Wang, K.
    Ross, J. S.
    Miller, V. A.
    Stephens, P. J.
    Daneker, G. W.
    Ali, S.
    Markman, M.
    CANCER RESEARCH, 2016, 76
  • [46] Biomarker Associations with Efficacy of Abiraterone Acetate and Exemestane in Postmenopausal Patients with Estrogen Receptor-Positive Metastatic Breast Cancer
    Li, Weimin
    O'Shaughnessy, Joyce
    Hayes, Daniel
    Campone, Mario
    Bondarenko, Igor
    Zbarskaya, Irina
    Brain, Etienne
    Stenina, Marina
    Ivanova, Olga
    Graas, Marie-Pascale
    Neven, Patrick
    Ricci, Deborah
    Griffin, Thomas
    Kheoh, Thian
    Yu, Margaret
    Gormley, Michael
    Martin, Jason
    Schaffer, Michael
    Zelinsky, Kathy
    De Porre, Peter
    Johnston, Stephen R. D.
    CLINICAL CANCER RESEARCH, 2016, 22 (24) : 6002 - 6009
  • [47] Integrated miRNA profiling of estrogen receptor-positive breast cancer cell MCF-7
    Bozkurt, S. B.
    Ozturk
    Kocak, N.
    Unlu, A.
    FEBS JOURNAL, 2015, 282 : 218 - 218
  • [48] Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen
    Loi, Sherene
    Haibe-Kains, Benjamin
    Desmedt, Christine
    Wirapati, Pratyaksha
    Lallemand, Francoise
    Tutt, Andrew M.
    Gillet, Cheryl
    Ellis, Paul
    Ryder, Kenneth
    Reid, James F.
    Daidone, Maria G.
    Pierotti, Marco A.
    Berns, Els Mjj
    Jansen, Maurice P. H. M.
    Foekens, John A.
    Delorenzi, Mauro
    Bontempi, Gianluca
    Piccart, Martine J.
    Sotiriou, Christos
    BMC GENOMICS, 2008, 9 (1)
  • [49] Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen
    Sherene Loi
    Benjamin Haibe-Kains
    Christine Desmedt
    Pratyaksha Wirapati
    Françoise Lallemand
    Andrew M Tutt
    Cheryl Gillet
    Paul Ellis
    Kenneth Ryder
    James F Reid
    Maria G Daidone
    Marco A Pierotti
    Els MJJ Berns
    Maurice PHM Jansen
    John A Foekens
    Mauro Delorenzi
    Gianluca Bontempi
    Martine J Piccart
    Christos Sotiriou
    BMC Genomics, 9
  • [50] Evolutionary analysis of 462 serial metastatic biopsies from 208 patients with estrogen receptor-positive (ER plus ) metastatic breast cancer (MBC) using whole exome sequencing (WES)
    Cohen, O.
    Buendia-Buendia, J.
    Wander, S.
    Nayar, U.
    Mao, P.
    Waks, A.
    Kim, D.
    Freeman, S.
    Adalsteinsson, V.
    Helvie, K.
    Livitz, D.
    Rosebrock, D.
    Leshchiner, I.
    Dellostritto, L.
    Garrido-Castro, A.
    Jain, E.
    Periyasamy, S.
    Mackichan, C.
    Lloyd, M.
    Marini, L.
    Krop, I.
    Garraway, L.
    Getz, G.
    Winer, E.
    Lin, N.
    Wagle, N.
    CANCER RESEARCH, 2019, 79 (04)
12345